Tired of effortful investing strategies with uncertain prospects? As a former deep value investor, I learned to appreciate the benefits of a dividend-focused value strategy several years ago. My strategy puts an emphasis on capital preservation and steadily growing income. I write primarily about stocks I hold in my diversified dividend stock portfolio, which emphasizes high-quality value stocks that offer meaningful growth and longterm safety. Feel free to reach out to me via direct messaging here, on Twit ...

New Product Line Features Two Moisturizers Designed to Defend and Support the Skin's Natural Collagen SKILLMAN, N.J., Aug. 15, 2024 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, is launching Neutrogena®1 Collagen Bank™ featuring the Company's patented micro-peptide technology. The launch propels Neutrogena®, the #1 Face Care Brand2, into the pre-aging category and is poised to meet the needs of Gen Z, a new generation ...

Vertigo3d/E+ via Getty Images Introduction Kenvue (NYSE:KVUE) recently reported its Q2 earnings on August 6th and continued successfully moving towards becoming a great, long-term stock for dividend investors. Breaking off from its parent company Johnson & Johnson (JNJ) last year, some investors may remain skeptical on what KVUE can become in the distant future. As a result of their strong portfolio of products, I think long-term investors could be catching the beginning of a successful road for the busines ...

nuttapong/iStock Editorial via Getty Images Introduction Last year, I started covering Johnson & Johnson (JNJ), one of the biggest healthcare companies in the world. However, the company, which sports a triple-A credit rating, got into trouble due to a number of lawsuits and weak growth. This turned it into an underperforming asset and forced it to make some radical decisions, including the spin-off of its consumer segment, which it had been streamlining since 2019. The spin-off has been a public company fo ...

Key Takeaways The S&P 500 rebounded on Tuesday, Aug. 6, 2024, adding 1% to notch its first positive session since economic concerns began roiling markets last week. Shares of Band-Aid parent Kenvue soared after the consumer health products company topped quarterly sales estimates and gave an upbeat outlook. Uber shares jumped after the ridesharing firm reported that second-quarter profits more than doubled from the prior year. Major U.S. equities indexes rebounded on Tuesday following three turbulent days o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-41697 | --- | --- | --- | --- | |-------------------------------------------------------------------|----------------|--------------------- ...

Kenvue Inc. (NYSE:KVUE) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Jim Giannakouros - Interim Head, Investor Relations Thibaut Mongon - Chief Executive Officer Paul Ruh - Chief Financial Officer Conference Call Participants Anna Lizzul - BofA Securities, Inc. Steve Powers - Deutsche Bank Securities, Inc. Andrea Teixeira - JPMorgan Securities LLC Nik Modi - RBC Capital Markets LLC Filippo Falorni - Citigroup Global Markets, Inc. Susan Anderson - Canaccord Genuity Jeremy F ...

Key Takeaways Kenvue affirmed its full-year revenue growth projection, the midpoint of which is above analysts' expectations. The Band-Aid owner reported second-quarter revenue that slightly beat consensus estimates. Kenvue shares soared 13% in intraday trading. Kenvue (KVUE) shares surged in intraday trading Tuesday after the company affirmed its full-year guidance that topped analysts' expectations. The Tylenol and Band-Aid parent, formerly the consumer healthcare unit of Johnson & Johnson (JNJ), continue ...

Among the key stocks in focus in today's session is Kenvue (NYSE:KVUE). The company, which was spun off from parent Johnson & Johnson (NYSE:JNJ) almost exactly one year ago, is seeing strong traction in the market today. KVUE stock is up 14% in early afternoon trading after the company reported its second-quarter results. As we highlighted already today, Kenvue's numbers were well ahead of analyst estimates. Kenvue beat on the top and bottom lines, with revenue of $4 billion coming in ahead of estimates of ...

Kenvue (KVUE) reported $4 billion in revenue for the quarter ended June 2024, representing a year-over-year decline of 0.3%. EPS of $0.32 for the same period compares to $0.32 a year ago. The reported revenue represents a surprise of +1.75% over the Zacks Consensus Estimate of $3.93 billion. With the consensus EPS estimate being $0.28, the EPS surprise was +14.29%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their nex ...